Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Farmocaine hydrochloride
RN: 16488-48-5
UNII: 5TL4JR7MPF
InChIKey: XTIUAXFQEAMQRU-UHFFFAOYSA-N

Classification Code

  • Drug / Therapeutic Agent

Molecular Formula

  • C17-H28-N2-O2.Cl-H

Molecular Weight

  • 328.881
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Results Name

  • Farmocaine hydrochloride

Name of Substance

  • p-Butylaminobenzoyldiethylaminoethyl hydrochloride [JAN]

Synonyms

  • 2-(Diethylamino)ethyl p-(butylamino)benzoate hydrochloride
  • Benzoe-diaethyl
  • Benzoe-diaethyl [German]
  • Depolipon
  • Ethanol, 2-(diethylamino)-, p-butylaminobenzoate, hydrochloride
  • Farmocaine HCl
  • Farmodent
  • Hydrochlorid salz des p-N-n-butylamino-benzoesaure-diaethylaminoaethylesters
  • Hydrochlorid salz des p-N-n-butylamino-benzoesaure-diaethylaminoaethylesters [German]
  • Neodent Green
  • p-Butylaminobenzoic acid, 2-(diethylamino)ethyl ester, monohydrochloride
  • p-Butylaminobenzoyl-N-(diethylamino)ethanol hydrochloride
  • p-Butylaminobenzoyldiethylaminoethyl hydrochloride
  • T-Cain
  • Teecaine
  • UNII-5TL4JR7MPF

Systematic Names

  • 2-(Diethylamino)ethyl p-(butylamino)benzoate hydrochloride
  • Benzoic acid, p-butylamino-, 2-(diethylamino)ethyl ester, monohydrochloride

Registry Numbers

CAS Registry Number

  • 16488-48-5

FDA UNII

  • 5TL4JR7MPF

System Generated Number

  • 0016488485

Molecular Formulas

Molecular Formula

  • C17-H28-N2-O2.Cl-H

Molecular Formula Fragments

  • C17-H28-N2-O2
  • Cl-H
  • COMPONENT

Structure Descriptors

InChI

1S/C17H28N2O2.ClH/c1-4-7-12-18-16-10-8-15(9-11-16)17(20)21-14-13-19(5-2)6-3;/h8-11,18H,4-7,12-14H2,1-3H3;1H

InChIKey

XTIUAXFQEAMQRU-UHFFFAOYSA-N

Smiles

c1(C(OCC[NH+](CC)CC)=O)ccc(NCCCC)cc1.[ClH-]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 31500ug/kg (31.5mg/kg)   Drugs in Japan Vol. -, Pg. 829, 1990.
mouse LD50 intravenous 4900ug/kg (4.9mg/kg) LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

BEHAVIORAL: MUSCLE WEAKNESS
Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 413, 1975.
mouse LD50 oral 156mg/kg (156mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 413, 1975.
mouse LD50 subcutaneous 19100ug/kg (19.1mg/kg)   Drugs in Japan Vol. -, Pg. 829, 1990.
rabbit LD50 intravenous 2400ug/kg (2.4mg/kg) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

BEHAVIORAL: MUSCLE WEAKNESS
Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 413, 1975.
rat LD50 intraperitoneal 20500ug/kg (20.5mg/kg)   Drugs in Japan Vol. -, Pg. 829, 1990.
rat LD50 intravenous 4mg/kg (4mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 1, Pg. 218, 1951.
rat LD50 subcutaneous 22500ug/kg (22.5mg/kg) BEHAVIORAL: MUSCLE WEAKNESS

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Oyo Yakuri. Pharmacometrics. Vol. 9, Pg. 413, 1975.